SOIVX
Price
$32.98
Change
-$0.10 (-0.30%)
Updated
Sep 20 closing price
VSMPX
Price
$256.96
Change
-$0.63 (-0.24%)
Updated
Sep 20 closing price
Ad is loading...

SOIVX vs VSMPX

Header iconSOIVX vs VSMPX Comparison
Open Charts SOIVX vs VSMPXBanner chart's image
Spirit of America Large Cap Value Inst
Price$32.98
Change-$0.10 (-0.30%)
VolumeN/A
CapitalizationN/A
Vanguard Total Stock Mkt Idx Instl Pls
Price$256.96
Change-$0.63 (-0.24%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
SOIVX vs VSMPX Comparison Chart
Loading...
VS
SOIVX vs. VSMPX commentary
Sep 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SOIVX is a StrongBuy and VSMPX is a Buy.

FUNDAMENTALS
Fundamentals
VSMPX has more cash in the bank: 1.72T vs. SOIVX (189M). SOIVX pays higher dividends than VSMPX: SOIVX (4.79) vs VSMPX (1.36). SOIVX was incepted earlier than VSMPX: SOIVX (4 years) vs VSMPX (9 years). SOIVX is a more actively managed with annual turnover of: 5.00 vs. VSMPX (2.00). SOIVX has a lower initial minimum investment than VSMPX: SOIVX (100000) vs VSMPX (100000000). SOIVX annual gain was more profitable for investors over the last year : 34.30 vs. VSMPX (25.90).
SOIVXVSMPXSOIVX / VSMPX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence4 years9 years-
Gain YTD26.13716.929154%
Front LoadN/AN/A-
Min. Initial Investment1000001000000000%
Min. Initial Investment IRAN/AN/A-
Net Assets189M1.72T0%
Annual Yield % from dividends4.791.36352%
Returns for 1 year34.3025.90132%
Returns for 3 years35.6721.36167%
Returns for 5 yearsN/A83.02-
Returns for 10 yearsN/AN/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
WU11.900.03
+0.25%
Western Union Company (The)
NIC97.310.03
+0.03%
Nicolet BanksharesInc
NEM53.06-0.05
-0.09%
Newmont Corp
ONTF6.07-0.11
-1.78%
ON24
TPST1.41-0.10
-6.62%
Tempest Therapeutics